[成人质瘤的系统性治疗:叙述性综述]
1Klinikai Központ, Pécsi Tudományegyetem, Általános Orvostudományi Kar, Onkoterápiás Intézet, Pécs, Hungary. mangel.laszlo@pte.hu.
Magyar onkologia
|March 14, 2024
概括
有效的质瘤治疗需要将局部疗法与化学疗法和免疫疗法等新型全身疗法结合起来. 整合分子标记物和成像的个性化治疗计划对于管理这些侵袭性脑瘤和预防复发至关重要.
科学领域:
- 神经瘤学神经瘤学
- 癌症治疗方法 癌症治疗方法
- 临床管理 临床管理
背景情况:
- 质瘤是具有高复发率的侵袭性脑瘤,经过手术和放射治疗等局部治疗后复发率很高.
- 现有的全身疗法,包括化疗和向药物,在长期有效性方面存在局限性.
- 对于改善质瘤的全身治疗策略,仍有大量未满足的需求.
研究的目的:
- 审查质瘤治疗方式的演变和当前景观.
- 突出系统疗法的作用,包括化疗,向药物和免疫疗法.
- 强调个性化,多模式治疗方法的重要性.
主要方法:
- 对质瘤的历史和当代治疗策略的审查.
- 对化疗剂,向疗法 (如VEGFR抑制剂) 和免疫疗法的分析.
- 在治疗规划中整合分子标记物和神经成像.
主要成果:
- 泰莫佐洛米德仍然是质瘤的基石化疗,用于单一治疗和组合治疗.
- 向疗法和免疫疗法已经成为有前途的全身治疗选择.
- 以分子标记和成像为指导的局部和全身治疗的个性化组合是最有效的.
结论:
- 虽然新型全身疗法显示出前景,但最优的质瘤管理依赖于个性化的多模式治疗计划.
- 将局部疗法与全身药物结合起来,考虑分子概况和成像,是初级和救援护理的关键.
- 以患者为中心的临床管理对于改善质瘤患者的治疗结果至关重要.
相关概念视频
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524


